contact us

SCIENTIFIC DEVELOPMENT OF A PUBLIC-PRIVATE CONSORTIUM


Innovative solutions in healthcare

 

Leading life-sciences companies in LATAM have partnered with prestigious public institutions to discover, develop and manufacture innovative biopharmaceuticals. With state-of-the-art technology and a production platform, the objective of this consortium is to contribute to next-generation solutions for human and animal health.

The partnership model enables articulating the prestigious tradition in scientific research of the public sector with the technology and production and managing capabilities of the private sector. Our networking model includes, among others, the biotech companies Chemo, mAbxience, Elea, Sinergium Biotech and Biogénesis Bagó, as well as the prestigious University of Buenos Aires, National Quilmes University, the Garrahan Children´s Hospital and the National Scientific and Technical Research Council (CONICET).

We lead with original lines of research in cancer, rare pediatric diseases, and other high-prevalence disorders. We have several molecules in early as well as late development stages. Our portfolio of biotechnology products includes the first therapeutic vaccine for the treatment of lung cancer (Vaxira®), a novel desmopressin analog for human and animal health and numerous biosimilars.

 

Read more >>

Companies

logo_elea_color.jpg
logo_bago_color.jpg
logo_pharmadn_color_2.jpg
logo_sinergium_color.jpg
chemo_logo_2011.jpg
recombio_emp.jpg

Organizations

logo_salud.jpg
logo_ciencia_tecnologia.jpg
logo_u_quilmes.jpg
cocinet.jpg
logo_senesa.jpg
hopital_pediatria.jpg
logo_academia.jpg
logo_inta.jpg
logo_u_plata.jpg
logo_roffo.jpg
logo_leloir.jpg
logo_school.jpg
logo_tecnologia.jpg
logo_uba_exactas.jpg